Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of GoodRx Holdings Inc (NASDAQ: GDRX) closed at $2.74 in the last session, up 2.24% from day before closing price of $2.68. In other words, the price has increased by $2.24 from its previous closing price. On the day, 1.94 million shares were traded. GDRX stock price reached its highest trading level at $2.7789 during the session, while it also had its lowest trading level at $2.69.
Ratios:
We take a closer look at GDRX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 5.25. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.11. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.89.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on August 09, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 15 ’25 when Spectrum Equity VII, L.P. sold 23,771 shares for $4.00 per share. The transaction valued at 95,103 led to the insider holds 0 shares of the business.
Spectrum VII Co-Investment Fun bought 8,569 shares of GDRX for $34,447 on Oct 15 ’25. On Oct 15 ’25, another insider, Spectrum VII Investment Manage, who serves as the Affiliate of the company, bought 15,202 shares for $4.02 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 952012928 and an Enterprise Value of 1201652480. As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 31.90, and their Forward P/E ratio for the next fiscal year is 6.23. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.11. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.16 while its Price-to-Book (P/B) ratio in mrq is 1.56. Its current Enterprise Value per Revenue stands at 1.501 whereas that against EBITDA is 9.054.
Stock Price History:
The Beta on a monthly basis for GDRX is 1.46, which has changed by -0.45306122 over the last 52 weeks, in comparison to a change of 0.12415576 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $5.81, while it has fallen to a 52-week low of $2.61. The 50-Day Moving Average of the stock is -23.23%, while the 200-Day Moving Average is calculated to be -35.10%.
Shares Statistics:
According to the various share statistics, GDRX traded on average about 3.74M shares per day over the past 3-months and 1866800 shares per day over the past 10 days. A total of 98.30M shares are outstanding, with a floating share count of 86.66M. Insiders hold about 74.47% of the company’s shares, while institutions hold 15.20% stake in the company. Shares short for GDRX as of 1763078400 were 7291578 with a Short Ratio of 1.95, compared to 1760486400 on 8252836. Therefore, it implies a Short% of Shares Outstanding of 7291578 and a Short% of Float of 7.739999999999999.
Earnings Estimates
The dynamic stock of GoodRx Holdings Inc (GDRX) is currently attracting attention from 11.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is $0.09, with high estimates of $0.11 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.38 and $0.34 for the fiscal current year, implying an average EPS of $0.36. EPS for the following year is $0.44, with 11.0 analysts recommending between $0.5 and $0.38.
Revenue Estimates
According to 12 analysts,. The current quarter’s revenue is expected to be $192.82M. It ranges from a high estimate of $194.7M to a low estimate of $191M. As of. The current estimate, GoodRx Holdings Inc’s year-ago sales were $198.58MFor the next quarter, 12 analysts are estimating revenue of $193.75M. There is a high estimate of $201.06M for the next quarter, whereas the lowest estimate is $183.37M.
A total of 14 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $796.7M, while the lowest revenue estimate was $793.2M, resulting in an average revenue estimate of $794.7M. In the same quarter a year ago, actual revenue was $792.32MBased on 15 analysts’ estimates, the company’s revenue will be $818.97M in the next fiscal year. The high estimate is $849.8M and the low estimate is $789.43M.
